Zaleplon capsules are the generic version of King Pharmaceuticals’s Sonata capsules, which had US sales of approximately $88 million for the 12 months ended March 31, 2008, according to IMS Health.
This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand, the company said.